118 related articles for article (PubMed ID: 8591697)
21. Increased secretion of 32,33 split proinsulin after intravenous glucose in glucose-tolerant first-degree relatives of patients with non-insulin dependent diabetes of European, but not Asian, origin.
Gelding SV; Andres C; Niththyananthan R; Gray IP; Mather H; Johnston DG
Clin Endocrinol (Oxf); 1995 Mar; 42(3):255-64. PubMed ID: 7758230
[TBL] [Abstract][Full Text] [Related]
22. Chronic sulfonylurea treatment and hyperglycemia aggravate disproportionately elevated plasma proinsulin levels in patients with type 2 diabetes.
Inoguchi T; Umeda F; Kakimoto M; Sako Y; Ishii H; Noda K; Kunisaki M; Imamura M; Yu HY; Etoh T; Yoshikawa H; Aoki T; Hashimoto T; Nawata H
Endocr J; 2000 Dec; 47(6):763-70. PubMed ID: 11228051
[TBL] [Abstract][Full Text] [Related]
23. True insulin and intact proinsulin levels in acromegalic patients.
Tavares EF; Dalbosco IS; Abucham J; Russo EM
Eur J Endocrinol; 1996 May; 134(5):549-53. PubMed ID: 8664973
[TBL] [Abstract][Full Text] [Related]
24. Immunoradiometric assay of insulin, intact proinsulin and 32-33 split proinsulin and radioimmunoassay of insulin in diet-treated type 2 (non-insulin-dependent) diabetic subjects.
Clark PM; Levy JC; Cox L; Burnett M; Turner RC; Hales CN
Diabetologia; 1992 May; 35(5):469-74. PubMed ID: 1521730
[TBL] [Abstract][Full Text] [Related]
25. Effect of linagliptin compared with glimepiride on postprandial glucose metabolism, islet cell function and vascular function parameters in patients with type 2 diabetes mellitus receiving ongoing metformin treatment.
Forst T; Anastassiadis E; Diessel S; Löffler A; Pfützner A
Diabetes Metab Res Rev; 2014 Oct; 30(7):582-9. PubMed ID: 24459063
[TBL] [Abstract][Full Text] [Related]
26. Both fasting and glucose-stimulated proinsulin levels predict hyperglycemia and incident type 2 diabetes: a population-based study of 9,396 Finnish men.
Vangipurapu J; Stančáková A; Kuulasmaa T; Kuusisto J; Laakso M
PLoS One; 2015; 10(4):e0124028. PubMed ID: 25853252
[TBL] [Abstract][Full Text] [Related]
27. Hyperproinsulinemia is not a characteristic feature in the offspring of patients with different phenotypes of type II diabetes.
Vauhkonen IK; Niskanen LK; Mykkänen L; Haffner SM; Uusitupa MI; Laakso M
Eur J Endocrinol; 2000 Aug; 143(2):251-60. PubMed ID: 10913945
[TBL] [Abstract][Full Text] [Related]
28. Fasting proinsulin concentrations predict the development of type 2 diabetes.
Wareham NJ; Byrne CD; Williams R; Day NE; Hales CN
Diabetes Care; 1999 Feb; 22(2):262-70. PubMed ID: 10333943
[TBL] [Abstract][Full Text] [Related]
29. Follow-up of women with previous GDM. Insulin, C-peptide, and proinsulin responses to oral glucose load.
Persson B; Hanson U; Hartling SG; Binder C
Diabetes; 1991 Dec; 40 Suppl 2():136-41. PubMed ID: 1748243
[TBL] [Abstract][Full Text] [Related]
30. Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance.
Davies MJ; Rayman G; Gray IP; Day JL; Hales CN
Diabet Med; 1993 May; 10(4):313-20. PubMed ID: 8508612
[TBL] [Abstract][Full Text] [Related]
31. Elevated Intact Proinsulin Levels During an Oral Glucose Challenge Indicate Progressive ß-Cell Dysfunction and May Be Predictive for Development of Type 2 Diabetes.
Pfützner A; Hermanns I; Ramljak S; Demircik F; Pfützner AH; Kann PH; Weber MM
J Diabetes Sci Technol; 2015 Sep; 9(6):1307-12. PubMed ID: 26420624
[TBL] [Abstract][Full Text] [Related]
32. The impact of insulin resistance on proinsulin secretion in pregnancy: hyperproinsulinemia is not a feature of gestational diabetes.
Retnakaran R; Hanley AJ; Sermer M; Zinman B
Diabetes Care; 2005 Nov; 28(11):2710-5. PubMed ID: 16249544
[TBL] [Abstract][Full Text] [Related]
33. Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy.
Rachman J; Levy JC; Barrow BA; Manley SE; Turner RC
Diabetes; 1997 Oct; 46(10):1557-62. PubMed ID: 9313749
[TBL] [Abstract][Full Text] [Related]
34. Serum insulin, proinsulin and proinsulin/insulin ratio in type 2 diabetic patients: as an index of beta-cell function or insulin resistance.
Kim NH; Kim DL; Choi KM; Baik SH; Choi DS
Korean J Intern Med; 2000 Dec; 15(3):195-201. PubMed ID: 11242807
[TBL] [Abstract][Full Text] [Related]
35. Disproportionately elevated proinsulin levels in type 2 diabetic patients treated with sulfonylurea.
Dworacka M; Abramczyk M; Winiarska H; Kuczynski S; Borowska M; Szczawinska K
Int J Clin Pharmacol Ther; 2006 Jan; 44(1):14-21. PubMed ID: 16425966
[TBL] [Abstract][Full Text] [Related]
36. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance.
Reaven GM; Chen YD; Hollenbeck CB; Sheu WH; Ostrega D; Polonsky KS
J Clin Endocrinol Metab; 1993 Jan; 76(1):44-8. PubMed ID: 8421101
[TBL] [Abstract][Full Text] [Related]
37. Serum lipoprotein levels and plasma concentrations of insulin, intact and 32, 33 split proinsulin in normoglycaemic relatives of patients with type 2 diabetes.
Gelding SV; Andres C; Niththyananthan R; Richmond W; Gray IP; Johnston DG
Diabet Med; 1994 Oct; 11(8):748-54. PubMed ID: 7851068
[TBL] [Abstract][Full Text] [Related]
38. Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes.
Røder ME; Dinesen B; Hartling SG; Houssa P; Vestergaard H; Sodoyez-Goffaux F; Binder C
Diabetes Care; 1999 Apr; 22(4):609-14. PubMed ID: 10189540
[TBL] [Abstract][Full Text] [Related]
39. Reduced pancreatic B cell compensation to the insulin resistance of aging: impact on proinsulin and insulin levels.
Røder ME; Schwartz RS; Prigeon RL; Kahn SE
J Clin Endocrinol Metab; 2000 Jun; 85(6):2275-80. PubMed ID: 10852463
[TBL] [Abstract][Full Text] [Related]
40. Insulin deficiency rather than hyperinsulinaemia in newly diagnosed type 2 diabetes mellitus.
Davies MJ; Metcalfe J; Gray IP; Day JL; Hales CN
Diabet Med; 1993 May; 10(4):305-12. PubMed ID: 8508611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
